Showing results (21-30 of 55) with videos related to

Sort By:
Pageof 6
Journal of Urban Health : Bulletin of the New York Academy of Medicine|October 11, 2007
Access to multilingual medication instructions at New York City pharmaciesLinda Weiss, Francesca Gany, Peri Rosenfeld, et al.
American Journal of Clinical Oncology|May 11, 2011
Management of single malignant lung nodules in elderly patients (70 years or older) who are not candidates for lobectomyBhupesh Parashar, Priti Patel, Prabhsimranjot Singh, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|July 26, 2012
Balloon catheter delivery of helper-dependent adenoviral vector results in sustained, therapeutic hFIX expression in rhesus macaquesNicola Brunetti-Pierri, Aimee Liou, Priti Patel, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|July 28, 2023
Single Nucleotide Polymorphisms in Cytokine Genes are Associated with the Susceptibility to Oral Squamous Cell CarcinomaRitu Pandey, Rajeev Nema, Supriya Vishwakarma, et al.
Public Health Reports (Washington, D.C. : 1974)|February 12, 2024
Hepatitis C Virus Testing, Infection, and Cases Reported Through Public Health Surveillance During Expanded Screening Recommendations, United States, 2013-2021Kathleen N Ly, Justin K Niles, Ruth B Jiles, et al.
Neuro-Oncology|January 18, 2020
Fyn tyrosine kinase, a downstream target of receptor tyrosine kinases, modulates antiglioma immune responsesAndrea Comba, Patrick J Dunn, Anna E Argento, et al.
British Journal of Clinical Pharmacology|September 17, 2021
Exposure-response analysis of acalabrutinib and its active metabolite, ACP-5862, in patients with B-cell malignanciesHelena Edlund, Núria Buil-Bruna, Karthick Vishwanathan, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 15, 2020
Pharmacodynamic Analysis of BTK Inhibition in Patients with Chronic Lymphocytic Leukemia Treated with AcalabrutinibAnfal Alsadhan, Jean Cheung, Michael Gulrajani, et al.
Pageof 6